Amgen (AMGN)

SG&A Expenses

$7.00B

TTM · Period ending: · USD

AMGN logo

AMGN SG&A Expenses

Latest reported$7.00B
AMGN TTM SG&A Expenses ($0.00 → $7.00B)
High-resolution chart · PNG

AMGN sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Amgen SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
7,004,000,000
6,950,000,000
7,035,000,000
6,976,000,000
6,881,000,000
6,975,000,000
7,096,000,000
7,492,000,000
7,220,000,000
6,729,000,000
6,179,000,000
5,477,000,000
5,411,000,000
5,444,000,000
5,414,000,000
5,267,000,000
5,285,000,000
5,342,000,000
5,368,000,000
5,716,000,000
5,757,000,000
5,668,000,000
5,730,000,000
5,470,000,000
5,347,000,000
5,312,000,000
5,150,000,000
5,196,000,000
5,266,000,000
5,359,000,000
5,332,000,000
5,200,000,000
5,077,000,000
4,933,000,000
4,870,000,000
4,766,000,000
4,840,000,000
4,923,000,000
5,062,000,000
5,155,000,000
5,155,000,000
5,023,000,000
4,846,000,000
4,757,000,000
4,726,000,000
4,702,000,000
4,699,000,000
4,893,000,000
4,929,000,000
5,049,000,000
5,184,000,000
5,033,000,000
4,915,000,000
4,890,000,000
4,811,000,000
4,649,000,000
4,643,000,000
4,542,000,000
4,486,000,000
4,434,000,000
4,266,000,000
4,122,000,000
3,983,000,000
4,007,000,000
3,982,000,000
3,906,000,000
3,820,000,000
3,751,000,000
3,719,000,000
3,713,000,000
3,789,000,000
3,679,000,000
3,509,000,000
3,465,000,000
3,361,000,000
3,390,000,000
3,467,000,000
3,447,000,000
3,366,000,000
3,247,000,000
3,096,000,000
2,902,000,000
2,790,000,000
2,695,000,000
2,671,000,000
2,616,000,000
2,556,000,000
2,366,000,000
2,217,000,000
2,067,200,000
1,940,300,000
1,815,200,000
1,727,100,000
1,606,400,000
1,462,100,000
1,287,400,000
1,114,300,000
1,020,300,000
970,700,000
893,700,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.